NYSE:CRL

Charles River Laboratories International Stock News

etoro logo Buy CRL
*Your capital is at risk
$232.51
-2.11 (-0.90%)
At Close: Jul 31, 2026
Charles River Laboratories International, Inc. (CRL) Presents at Evercore 8th Annual Healthcare Conference Transcript
Shareholders should contact the firm immediately as there may be limited time to enforce your rights.   NEW YORK , Dec. 1, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is inve
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Evercore Healthcare Conference.
Creative Planning lifted its position in shares of Charles River Laboratories International, Inc. (NYSE: CRL) by 7.1% in the second quarter, according to its most recent filing with the Securities and
The small cap team initiated a new investment position in Hexcel Corporation. Hexcel is a global leader in advanced composite materials. We initiated a position in Charles River Labs in Q3. CRL is a h
Charles River Laboratories International, Inc. ( CRL ) Jefferies London Healthcare Conference 2025 November 18, 2025 6:30 AM EST Company Participants Birgit Girshick - Corporate Executive VP & COO Con
STAMFORD, Conn.--(BUSINESS WIRE)--SOLVE, the leading provider of pre-trade data and predictive pricing for fixed income securities markets, today announced a new partnership with Charles River Develop
Explore how Charles River's (CRL) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Jefferies Global Healthcare Conference.
Wellness Center Usa (OTCMKTS:WCUI - Get Free Report) and Charles River Laboratories International (NYSE: CRL - Get Free Report) are both medical companies, but which is the superior stock? We will con
Bank of New York Mellon Corp boosted its stake in shares of Charles River Laboratories International, Inc. (NYSE: CRL) by 11.8% during the undefined quarter, according to its most recent Form 13F fili
Charles River Laboratories International, Inc. ( CRL ) Q3 2025 Earnings Call November 5, 2025 9:00 AM EST Company Participants Todd Spencer - Corporate Vice President of Investor Relations James Foste
Charles River Laboratories International Inc. (NYSE:CRL) stock is trading lower on Wednesday after the company released third-quarter 2025 earnings. It also provided an update on the company's strateg
Charles River Laboratories remains a "Hold" as strategic review yields minimal change and a sale is unlikely. CRL faces slow organic growth, shrinking backlog, and ongoing pressure in its core DSA seg
While the top- and bottom-line numbers for Charles River (CRL) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE